Vasoconstriction

Name
Vasoconstriction
Accession Number
DBCAT004353
Description

Not Available

Drugs
DrugDrug Description
OxymetazolineAn alpha-1A adrenoceptor agonist used to treat nasal congestion, allergic reactions of the eye, and facial erythema associated with rosacea.
Angiotensin IIA peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock.
VasopressinA peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy.
Drugs & Drug Targets
DrugTargetType
OxymetazolineAlpha-1A adrenergic receptortarget
OxymetazolineAlpha-2A adrenergic receptortarget
OxymetazolineAlpha-2C adrenergic receptortarget
OxymetazolineAlpha-2B adrenergic receptortarget
OxymetazolineAlpha-1B adrenergic receptortarget
OxymetazolineAlpha-1D adrenergic receptortarget
Oxymetazoline5-hydroxytryptamine receptor 1Atarget
Oxymetazoline5-hydroxytryptamine receptor 1Btarget
Oxymetazoline5-hydroxytryptamine receptor 1Dtarget
Oxymetazoline5-hydroxytryptamine receptor 1Ctarget
OxymetazolineUDP-glucuronosyltransferase 1-9enzyme
OxymetazolineCytochrome P450 2C19enzyme
Angiotensin IIType-1 angiotensin II receptortarget
VasopressinVasopressin V1a receptortarget
VasopressinVasopressin V2 receptortarget
VasopressinVasopressin V1b receptortarget
VasopressinCanalicular multispecific organic anion transporter 1transporter
VasopressinOxytocin receptortarget